John Fesko sold $2.1M of Natera (NTRA)

Executed Aug 10, disclosed Aug 29, 18 days later, against a two-business-day limit.

Value, as filed

$2.1M

6,517 sh × $321.53

Executed

Aug 10

the trade date, as filed

Disclosed

Aug 29

18 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

John Fesko PRESIDENT, CHIEF BUS. OFFICER profile →

John Fesko (PRESIDENT, CHIEF BUS. OFFICER) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales, 1 filed past the two-business-day deadline), most often in Natera, Inc. (NTRA). The largest single filing was $4.2M of NTRA (17,806 sh × $234.74, as filed), executed Jan 20.

The name

NTRA

Natera, Inc. NTRA · Healthcare · 219 filings in 24 months ticker →

Healthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John Fesko in NTRA

NTRASALE Natera, Inc. $440K
1,713 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET NTRASALE Natera, Inc. $292K
1,438 sh × $202.84
Exec May 26
Filed May 28 · 5:30 PM ET NTRASALE Natera, Inc. $345K
1,688 sh across 2 lots
Exec Apr 27
Filed Apr 29 · 5:30 PM ET NTRASALE Natera, Inc. $144K
707 sh × $204.13
Exec Mar 10
Filed Mar 11 · 5:30 PM ET NTRASALE Natera, Inc. $830K
3,594 sh across 2 lots
Exec Feb 3
Filed Feb 4 · 5:30 PM ET NTRASALE Natera, Inc. $409K
1,712 sh across 2 lots
Exec Jan 27
Filed Jan 29 · 5:30 PM ET NTRASALE Natera, Inc. $4.2M
17,806 sh × $234.74
Exec Jan 20
Filed Jan 22 · 5:30 PM ET NTRASALE Natera, Inc. $328K
1,709 sh across 2 lots
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET